HSIC Q2 Deep Dive: AI, Value Creation, and Specialty Products Drive Growth

Dental and medical products company Henry Schein (NASDAQ:HSIC) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.7% year on year to $3.46 billion. Its non-GAAP profit of $1.27 per share was 2.5% above analysts’ consensus estimates.

Is now the time to buy HSIC? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Henry Schein delivered a positive second quarter, with results exceeding Wall Street’s expectations and earning a strong market response. Management attributed the outperformance to accelerating internal sales growth, robust gains in its global dental merchandise segment, and early benefits from value creation initiatives. CEO Frederick Lowery emphasized the company’s success in converting occasional buyers into engaged customers and highlighted strong market share gains, particularly in the U.S. and Canada. The company also cited the expansion of its Henry Schein One technology platform and growth in its own-brand and specialty products as key contributors to the quarter’s momentum.

Looking ahead, Henry Schein’s updated guidance is shaped by continued investments in technology, operational efficiency, and portfolio optimization. Management believes further growth will be fueled by expanding AI-enabled capabilities in its practice management software, ongoing value creation projects targeting at least $200 million in operating income improvements, and targeted growth in specialty products and home healthcare. CFO Ronald South outlined plans to phase in additional outsourcing and procurement initiatives, while Lowery noted, “Our vision is to become the platform that helps healthcare practitioners operate better practices, creating sustainable value for both customers and shareholders.”

Key Insights from Management’s Remarks

Management credited the quarter’s growth to rising demand for AI-driven technology, strong own-brand product momentum, and operational streamlining, while also highlighting portfolio and leadership changes to enhance execution.

• AI-powered software adoption: The company’s Henry Schein One platform continued to see strong uptake, with nearly 13,000 customers now subscribed to cloud-based practice management solutions such as Dentrix Ascend. Embedded AI capabilities—including voice-enabled clinical notes and automated claims management—were cited as drivers of customer engagement and higher monthly revenue per user.
• Own brands and exclusives gaining share: Proprietary and corporate brand products outpaced third-party merchandise growth, nearly doubling the rate of other merchandise categories. Management noted this shift supported both market share gains and improved gross margins.
• Specialty and international strength: The specialty products group, particularly dental implants, saw robust growth in Europe and increasing traction in the U.S. The premium Camlog brand led gains in Central Europe, while the recently acquired S.I.N. 360 strengthened the company’s U.S. value implant offering.
• Operational efficiency initiatives: The company advanced value creation projects including global outsourcing for finance and customer service, centralized procurement, and dynamic pricing. These efforts are expected to contribute at least $200 million in operating income improvements over several years, with initial benefits already visible in Q2 results.
• Leadership and organizational changes: New executive team structures were implemented to accelerate decision-making, streamline operations, and bring leadership closer to customers. Long-serving executives transitioned to advisory roles to support continuity during this shift.

Drivers of Future Performance

Henry Schein’s outlook centers on technology adoption, operational discipline, and expansion in high-growth areas, balanced by ongoing investments and market-specific dynamics.

• Expanded technology and AI capabilities: Management plans to broaden AI integration within its cloud-based practice management platforms, enabling practices to analyze their own data and identify new revenue opportunities. This is expected to deepen customer relationships and increase recurring revenue, as nearly 90% of Henry Schein One’s sales are subscription-based.
• Value creation and cost savings: The company aims to deliver at least $200 million in operating income improvements by extending outsourcing, procurement, and supply chain software projects. While about 40% of near-term benefits are from higher gross profits (such as improved pricing and own-brand mix), greater G&A savings are targeted in later phases.
• Growth in specialty and medical segments: Management foresees continued expansion in specialty dental products—particularly implants in Europe and value brands in the U.S.—as well as strong performance from the Home Solutions medical business. However, slow growth in U.S. premium implants and headwinds in diagnostic testing are expected to persist.

Catalysts in Upcoming Quarters

Going forward, the StockStory team will watch (1) the pace of AI-enabled technology adoption and its impact on recurring revenue, (2) realization of targeted value creation and cost savings, especially as outsourcing and procurement initiatives expand, and (3) further gains in specialty dental and Home Solutions medical segments. Continued execution on portfolio optimization and integration of new leadership structures will also be critical markers for progress.

Henry Schein currently trades at $89.10, up from $86.51 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

High Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.